Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response

PLoS Pathog. 2019 May 20;15(5):e1007691. doi: 10.1371/journal.ppat.1007691. eCollection 2019 May.

Abstract

Cyclic GMP-AMP synthase (cGAS) senses viral DNA in the cytosol and then catalyzes synthesis of the second messenger cGAMP, which activates the ER-localized adaptor protein Mediator of IRF3 Activator (MITA) to initiate innate antiviral response. Human cytomegalovirus (HCMV) proteins can antagonize host immune responses to promote latent infection. Here, we identified HCMV UL42 as a negative regulator of cGAS/MITA-dependent antiviral response. UL42-deficiency enhances HCMV-induced production of type I interferons (IFNs) and downstream antiviral genes. Consistently, wild-type HCMV replicates more efficiently than UL42-deficient HCMV. UL42 interacts with both cGAS and MITA. UL42 inhibits DNA binding, oligomerization and enzymatic activity of cGAS. UL42 also impairs translocation of MITA from the ER to perinuclear punctate structures, which is required for MITA activation, by facilitating p62/LC3B-mediated degradation of translocon-associated protein β (TRAPβ). These results suggest that UL42 can antagonize innate immune response to HCMV by targeting the core components of viral DNA-triggered signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cytomegalovirus / drug effects
  • Cytomegalovirus / immunology*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / immunology*
  • Cytomegalovirus Infections / metabolism
  • Cytomegalovirus Infections / virology
  • DNA, Viral / genetics
  • DNA, Viral / metabolism
  • HEK293 Cells
  • Humans
  • Immunity, Innate / immunology*
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism*
  • Signal Transduction
  • Viral Proteins / pharmacology*

Substances

  • Antiviral Agents
  • DNA, Viral
  • Membrane Proteins
  • STING1 protein, human
  • Viral Proteins
  • Nucleotidyltransferases
  • cGAS protein, human

Grants and funding

This study was supported by the National Science Fund for Distinguished Young Scholars (31425010, awarded to Y.Y.W.), the National Natural Science Foundation of China (31621061, awarded to Y.Y.W.; 31800732, awarded to Y.Z.F.), the Ministry of Science and Technology of China (2015CB554302, awarded to Y.Y.W.), the Strategic Pilot Project (XDB29010302, awarded to Y.Y.W) and Key Research Programs of Frontier Sciences (awarded to Y.Y.W) funded by the Chinese Academy of Sciences, the National Postdoctoral Program for Innovative Talents (BX201700277, awarded to Y.Z.F) and China Postdoctoral Science Foundation (2018M630894, awarded to Y.Z.F).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.